##gff-version 3
##sequence-region Q8N1G0 1 1237
Q8N1G0	UniProtKB	Chain	1	1237	.	.	.	ID=PRO_0000234005;Note=Zinc finger protein 687	
Q8N1G0	UniProtKB	Zinc finger	533	552	.	.	.	Note=C2H2-type 1%3B degenerate;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q8N1G0	UniProtKB	Zinc finger	705	727	.	.	.	Note=C2H2-type 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q8N1G0	UniProtKB	Zinc finger	764	787	.	.	.	Note=C2H2-type 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q8N1G0	UniProtKB	Zinc finger	792	815	.	.	.	Note=C2H2-type 4;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q8N1G0	UniProtKB	Zinc finger	827	849	.	.	.	Note=C2H2-type 5;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q8N1G0	UniProtKB	Zinc finger	858	881	.	.	.	Note=C2H2-type 6;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q8N1G0	UniProtKB	Zinc finger	963	986	.	.	.	Note=C2H2-type 7;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q8N1G0	UniProtKB	Zinc finger	993	1016	.	.	.	Note=C2H2-type 8;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q8N1G0	UniProtKB	Zinc finger	1135	1158	.	.	.	Note=C2H2-type 9;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q8N1G0	UniProtKB	Zinc finger	1200	1222	.	.	.	Note=C2H2-type 10;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q8N1G0	UniProtKB	Compositional bias	130	305	.	.	.	Note=Pro-rich	
Q8N1G0	UniProtKB	Compositional bias	322	325	.	.	.	Note=Poly-Ser	
Q8N1G0	UniProtKB	Compositional bias	922	926	.	.	.	Note=Poly-Ser	
Q8N1G0	UniProtKB	Compositional bias	927	930	.	.	.	Note=Poly-Glu	
Q8N1G0	UniProtKB	Compositional bias	955	962	.	.	.	Note=Poly-Gly	
Q8N1G0	UniProtKB	Modified residue	102	102	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9D2D7	
Q8N1G0	UniProtKB	Modified residue	129	129	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q8N1G0	UniProtKB	Modified residue	140	140	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:21406692,PMID:23186163	
Q8N1G0	UniProtKB	Modified residue	148	148	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q8N1G0	UniProtKB	Modified residue	227	227	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8N1G0	UniProtKB	Modified residue	242	242	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8N1G0	UniProtKB	Modified residue	251	251	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21406692;Dbxref=PMID:21406692	
Q8N1G0	UniProtKB	Modified residue	253	253	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q8N1G0	UniProtKB	Modified residue	266	266	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q8N1G0	UniProtKB	Modified residue	271	271	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q8N1G0	UniProtKB	Modified residue	374	374	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:21406692,PMID:23186163	
Q8N1G0	UniProtKB	Modified residue	377	377	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8N1G0	UniProtKB	Modified residue	433	433	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:21406692,PMID:23186163	
Q8N1G0	UniProtKB	Modified residue	495	495	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:19690332,PMID:23186163	
Q8N1G0	UniProtKB	Modified residue	900	900	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8N1G0	UniProtKB	Modified residue	1057	1057	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:17081983,PMID:19369195,PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q8N1G0	UniProtKB	Modified residue	1060	1060	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9D2D7	
Q8N1G0	UniProtKB	Modified residue	1082	1082	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q8N1G0	UniProtKB	Modified residue	1083	1083	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q8N1G0	UniProtKB	Modified residue	1085	1085	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q8N1G0	UniProtKB	Modified residue	1101	1101	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9D2D7	
Q8N1G0	UniProtKB	Modified residue	1106	1106	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q8N1G0	UniProtKB	Modified residue	1118	1118	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q8N1G0	UniProtKB	Modified residue	1184	1184	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9D2D7	
Q8N1G0	UniProtKB	Modified residue	1191	1191	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:24275569	
Q8N1G0	UniProtKB	Modified residue	1211	1211	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q8N1G0	UniProtKB	Cross-link	285	285	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	336	336	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	372	372	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	384	384	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	397	397	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	422	422	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	435	435	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	439	439	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	451	451	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	464	464	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	954	954	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8N1G0	UniProtKB	Cross-link	1043	1043	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q8N1G0	UniProtKB	Alternative sequence	1027	1103	.	.	.	ID=VSP_018168;Note=In isoform 2. YCTEGKRTFSSRLILEKHVQVRHGLQLGAQSPGRGTTLARGSSARAQGPGRKRRQSSDSCSEEPDSTTPPAKSPRGG->SKGPGLRAVPLLPSCPLPFQVLHRGKTHLQQPPDPRETCPGPARLAAWGPVPWPGDHLGSGFQCQSPGARSETPPVF;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q8N1G0	UniProtKB	Alternative sequence	1104	1237	.	.	.	ID=VSP_018169;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q8N1G0	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_076534;Note=In PDB6%3B unknown pathological significance. S->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26849110;Dbxref=dbSNP:rs869025582,PMID:26849110	
Q8N1G0	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_052894;Note=G->E;Dbxref=dbSNP:rs3748545	
Q8N1G0	UniProtKB	Natural variant	344	344	.	.	.	ID=VAR_052895;Note=R->T;Dbxref=dbSNP:rs12045766	
Q8N1G0	UniProtKB	Natural variant	937	937	.	.	.	ID=VAR_076535;Note=In PDB6%3B enhances nuclear localization%3B increases expression levels%3B R-937 containing osteoclasts induced by treatment of peripheral blood mononuclear cells with CSF1 and TNFSF11 exhibit a greater number of nuclei%2C as well as a larger surface area than did those from the control individuals. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26849110;Dbxref=dbSNP:rs148402804,PMID:26849110	
Q8N1G0	UniProtKB	Sequence conflict	331	331	.	.	.	Note=R->W;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8N1G0	UniProtKB	Sequence conflict	439	439	.	.	.	Note=K->E;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8N1G0	UniProtKB	Sequence conflict	515	515	.	.	.	Note=R->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8N1G0	UniProtKB	Sequence conflict	639	639	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
